NYSE · Healthcare · Healthcare Plans · USA
CVS Health Corp is a large cap company (market value between $10 billion and $200 billion) in the Healthcare Plans industry.
CVS Health operates as a diversified health care company providing insurance coverage and medical services through its Aetna operations. The company offers traditional and consumer-directed health insurance products including medical, dental and behavioral health plans, Medicare Advantage, prescription drug coverage, and Medicaid services. It also runs retail pharmacy locations and primary care clinics.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the CVS Health Corp stock.
Slightly overvalued: intrinsic value $78.94 per share, market price $92.68, margin of safety -17.4% (as of 2026-10-19).
Discounting its cash flows at 7.3% (average of 3 methods) values the shares at $78.94; the price of $92.68 is 17% above that value, and 82% of that value comes from beyond year five.
Leak Score: 44/100 on 11 of 12 signals (On Watch).
17 more funds hold it; the full list is part of the paid plan.
All 11 Healthcare Plans stocks
1 more in this industry show a wider margin of safety.
CVS is slightly overvalued (as of the 2026-10-19 close). Discounting its cash flows at 7.3% (average of 3 methods) values the shares at $78.94; the price of $92.68 is 17% above that value, and 82% of that value comes from beyond year five.
$78.94 per share (as of the 2026-10-19 close), against a market price of $92.68. That is a margin of safety of -17.4%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.
The price asks for roughly the growth the company has already delivered. No miracle needed, no discount either. Yearly sales growth the price needs: 13.2%. Yearly sales growth it has sustained: 8.7%.
44 out of 100, which we rate "On Watch", on 11 of 12 value investing signals.